Flagship Pioneering is an American life sciences company based in Cambridge, Massachusetts[1][2][3] that founds biotechnology, life sciences, health and sustainability companies, including the biotechnology company Moderna.[4] The firm is known for funding companies that it creates and incubates in-house.[5]
The company was founded in Cambridge in 1999 by Noubar Afeyan under the name NewcoGen (short for "new company generation"). A few years later, the name was changed to Flagship Ventures, and again in 2016 to Flagship Pioneering.[2]
In late 2010, Flagship formed Moderna, which focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA (mRNA).[4][6]